AustraliaHealth

Clarity Pharmaceuticals (ASX:CU6) has announced a landmark commercial manufacturing agreement with Nucleus RadioPharma.

Monash IVF Group (ASX:MVF) has entered a critical period of negotiation following a revised, non-binding indicative proposal from a high-profile consortium.

Talius Group (ASX:TAL) has secured a master services agreement with Seventh-Day Adventist Aged Care (South Queensland).

Pro Medicus (ASX:PME) announced a five-year contract renewal with Chicago-based Northwestern Medicine.

Telix Pharmaceuticals (ASX:TLX) and Regeneron Pharmaceuticals (NASDAQ:REGN) have announced a global collaboration.

The US FDA has accepted Telix Pharmaceuticals' (ASX:TLX) NDA for brain cancer imaging agent Pixclara.

AVITA Medical (ASX:AVH) has finalised a ten-year agreement with the Biomedical Advanced Research and Development Authority valued at up to $25.5 million.

FDA clears Mesoblast (ASX:MSB) will begin a registrational trial for Ryoncil in treating Duchenne muscular dystrophy.

Imricor Medical Systems (ASX:IMR) submitted its NorthStar 3D Mapping System for FDA clearance.

Lumos Diagnostics (ASX:LDX) announced a new three-year contract manufacturing agreement for the innovative Micro-Pak Mold Analyser system.

Radiopharm Theranostics (ASX:RAD) reached a clinical milestone following a positive recommendation from the Data Safety and Monitoring Committee.

Pro Medicus (ASX:PME) secured a five-year, $23 million contract with the University of Maryland Medical System.